Disc Medicine Shares Lower After Q3 Results

10:26 AM EST, 11/05/2026 (MT Newswires) -- Disc Medicine (IRON) shares were over 2% lower in Thursday trading following its Q3 financial results. Earlier, the company reported a Q3 net loss of $1.53 per diluted share, narrower than a loss of $1.77 a year earlier. Analysts polled by FactSet expected a loss of $1.63. The clinical-stage firm said it has sufficient funds to operate through 2030. As of Sept. 30, it had $682.8 million in cash, cash equivalents, and marketable securities. Price: 81.41, Change: -1.88, Percent Change: -2.25